R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Coalition issues rallying cry to takes the fight against AMR...

Team up, wake up, and act before AMR turns back the clock on medical advances, say the cross-sector team behind the Infection Management Coalition.

R&D

Deep Dive: Research and Development

Fuelled by advancements in technology and computing, R&D in life sciences is undergoing a fundamental transformation that puts patients at the heart of research.

R&D

Examining COVID’s impact on clinical research participant di...

The clinical research industry has long struggled with participant diversity.

R&D

New HIV variant highlights the importance of monitoring viru...

Researchers discovered a highly virulent variant of HIV in the Netherlands that genetic sequence analysis suggests has been circulating since the 1990s.

R&D

Why was R&D productivity up in 2021?

A recent report has found that R&D productivity rose vertiginously during 2021, but how much of this was organic and how much can be attributed to the pandemic?

Oncology

Cancer vaccines: providing the edge in oncology

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector.